Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Recurrence × obinutuzumab × Clear all

Phase

Status

Completed 4 Recruiting 3 Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1

Interventions

zanubrutinib 1 venetoclax 1 tazemetostat 1 obinutuzumab 1 brincidofovir 1 Rituximab 1 Propranolol 1 Curettage 1 CA-4948 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡